News Study Supports Earlier Start for Geographic Atrophy Drug by Medscape • 2025/09/17 • 0 Comments Patients who start on pegcetacoplan for geographic atrophy at the outset of a 4-year study retain almost three times more macular tissue than those who wait to begin treatment. Medscape Medical News